Physician profile
Bindesh Kiritkumar Patel
NPI 1063478956
$1,213.83
in general payments reported to CMS, 2019-2025
12 companies · $723 in 2025
The $723 reported for 2025 was more than what 80% of Undersea and Hyperbaric Medicine (Preventive Medicine) providers received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.18 · 2022: $61.04 · 2023: $74.41 · 2024: $294 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $525.71 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Solventum Corporation | $193.41 | 2024-2025 | Prevena, Activ.A.C. |
| Smith+Nephew, INC. | $172.21 | 2022-2025 | Collagenase Santyl, Pico 7, Grafix Pl |
| Urgo Medical North America, LLC | $71.54 | 2024-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Organogenesis INC. | $52.80 | 2023-2025 | Apligraf, Puraply |
| Paratek Pharmaceuticals, INC. | $40.04 | 2025 | Nuzyra |
| Hartmann USA, INC. | $37.21 | 2021-2024 | Zetuvit Plus 10x10 P10 |
| Tactile Systems Technology INC | $28.54 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Davol INC. | $26.64 | 2025 | Arista |
| Misonix INC | $24.61 | 2021 | |
| Bsn Medical INC | $23.68 | 2022 | |
| Kci USA, INC. | $17.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bindesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.